You are here

Subscribe

Prostate & Urologic Cancer Center Blog

All
All

DCI Center for Prostate & Urologic Cancers Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Jessica Hyland, Editor-In-Chief.

DCI Center for Prostate & Urologic Cancers Present at EAU

Physician-scientists from DCI Center for Prostate & Urologic Cancers recently presented data at the 2019 European Association of Urology (EAU) Congress held in Barcelona, Spain, from March 15 -19. Held annually, over 10,000 colleagues throughout the world gather for the scientific retreat to...

Blood Tests Predict Effectiveness of Hormonal Therapies

A multi-institutional group of clinical researchers, led by the Duke Cancer Institute’s Andrew Armstrong, MD, McS, FACP, published a new report this month in the Journal of Clinical Oncology , that describes results from the PROPHECY study, which prospectively compared two blood tests to assess how...

Duke Hosts Urologic Assembly & Urologic Cancer Symposium

Duke Urology will host the 51st annual Leading Edge Urology: Duke Urologic Assembly & Urologic Cancer Symposium from March 28 — 31 in Orlando, Florida. This educational conference features lectures by Duke faculty and guest urologists, medical and radiation oncologists. “At Duke, we have...

McNamara Receives PCF Young Investigator Award

Megan McNamara, MD, has been named one of 29 Prostate Cancer Foundation Young Investigator Award recipients for 2018. McNamara is also one of only eleven PCF Young Investigator Awardees conducting research to improve prostate cancer outcomes in U.S. veterans. The award includes three years of...

Duke Researchers Awarded $ 1 Million For Prostate Cancer Research

A team of researchers led by Duke Cancer Institute scientists Steven Patierno, PhD; Daniel George, MD; Jennifer Freedman, PhD; Jiaoti Huang, MD, PhD and Amanda Hargrove, PhD have been awarded a Movember Foundation-Prostate Cancer Foundation Challenge Award. The project includes a number of key co-...

Prostate Cancer Patient Stays In The Game

It’s an early Monday morning as Robert Dixon, 58, strolls into Duke Cancer Center. He greets the staff behind the information desk before heading over to the elevators, descending down a couple floors to clinic 00. Today is his first appointment with his radiation oncologist. A few months ago,...

Farmer Remains True To His Roots During Cancer Treatment

As a child growing up in the 1950s, Ernest “Otto” Griffin, spent a great deal of time outdoors working on his family’s farm in Seven Springs, North Carolina. Those years sparked a love of agriculture in Griffin, who eventually became the head forester at Duke Forest. As famous forester Jack C...

Somarelli Awarded Prostate Cancer Research Funding

A team of researchers led by Duke Cancer Institute scientist Jason Somarelli, PhD, has been awarded a Prostate Cancer Research Program (PCRP) Idea Development Award — New Investigator, totaling $350,000, by the United States Department of Defense Office of Congressionally Directed Medical Research...

Man Dedicates Life To Moving Research Further

The beeping monitor disrupts the stillness that fills Roger Bryant’s hospital room. Beth, his wife of 23 years, gently caresses his head as she shares stories of his life with the nurse adjusting his pain medication. Every now and then, Roger faintly smiles at something Beth mumbles, silently...

Blurring The Racial Lines On Prostate Cancer

An increased survival benefit for African-American men with advanced prostate cancer and a stronger response to hormone therapy were the centerpieces of key racial disparity studies presented by researchers from Duke’s Prostate & Urologic Cancer Center at the 2018 American Society of Clinical...

Researchers Identify Promising New Drug Target for Lethal Prostate Cancer

Targeting a protein genome-binding process that directs expression of diverse cancerous genes could be an important new therapy approach for stopping the progression of late-stage prostate cancer, according to Duke researchers. The study , published Tuesday, May 29, 2018 in the journal Proceedings...

Tests Identify When Advanced Prostate Cancer Therapies Would Benefit

Two blood tests can predict which subset of men with advanced prostate cancer will likely not benefit from anti-androgen therapies, providing doctors and patient added clarity on treatment options, according to a study led by Duke Cancer Institute . The blood tests, dubbed “liquid biopsies”, detect...

Pages